$3.00 pps sounds reasonable to me, I guess we will just have to find investors willing to pay $3/share for NVIV.
I currently have a fair amount of money in NVIV, and if the technology works and SCI patients start to recover using the NVIV scaffold treatment, then we should easily see $3.00 and a lot more.
We may see more investors take a chance on NVIV, since the upside is great and the downside is somewhat limited, so the pps might continue to move upward.
I am holding my shares waiting for the patient enrollments to start and outcome data to be released.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.